The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J.-P. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,081
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones
Mayer, M. L., Westbrook, G. L., & Guthrie, P. B. (1984) · Nature · doi:10.1038/309261a0 · Cited by 2,893
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95
Kornau, H.-C., Schenker, L. T., Kennedy, M. B., & Seeburg, P. H. (1995) · Science · doi:10.1126/science.7569905 · Cited by 1,904
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
PDZ domain proteins of synapses
Kim, E., & Sheng, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1517 · Cited by 1,577
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248
Glutamate receptors in the mammalian central nervous system
Ozawa, S., Kamiya, H., & Tsuzuki, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00085-3 · Cited by 1,122
Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity
Liu, L., Wong, T. P., Pozza, M. F., Lingenhoehl, K., Wang, Y., Sheng, M., Auberson, Y. P., & Wang, Y. T. (2004) · Science · doi:10.1126/science.1096615 · Cited by 1,102
The Toxic Effect of Sodium L-Glutamate on the Inner Layers of the Retina
LUCAS, D. R., & NEWHOUSE, J. P. (1957) · Archives of Ophthalmology · doi:10.1001/archopht.1957.00940010205006 · Cited by 1,063
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., & Masu, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53849-7 · Cited by 979
N-methyl-D-aspartic acid receptor structure and function
McBain, C. J., & Mayer, M. L. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.3.723 · Cited by 976
Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation
Chen, L., & Mae Huang, L.-Y. (1992) · Nature · doi:10.1038/356521a0 · Cited by 965
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Specific Coupling of NMDA Receptor Activation to Nitric Oxide Neurotoxicity by PSD-95 Protein
Sattler, R., Xiong, Z., Lu, W.-Y., Hafner, M., MacDonald, J. F., & Tymianski, M. (1999) · Science · doi:10.1126/science.284.5421.1845 · Cited by 834
MCGEER, E. G., & MCGEER, P. L. (1976) · Nature · doi:10.1038/263517a0 · Cited by 834
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 800
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
Tovar, K. R., & Westbrook, G. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04180.1999 · Cited by 786
Reynolds, I., & Hastings, T. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03318.1995 · Cited by 777
Src kinases: a hub for NMDA receptor regulation
Salter, M. W., & Kalia, L. V. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1368 · Cited by 776
Dugan, L., Sensi, S., Canzoniero, L., Handran, S., Rothman, S., Lin, T., Goldberg, M., & Choi, D. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06377.1995 · Cited by 772
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Selective Sparing of a Class of Striatal Neurons in Huntington's Disease
Ferrante, R. J., Kowall, N. W., Beal, M. F., Richardson, E. P., Bird, E. D., & Martin, J. B. (1985) · Science · doi:10.1126/science.2931802 · Cited by 757
Schilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 753
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Massey, P. V., Johnson, B. E., Moult, P. R., Auberson, Y. P., Brown, M. W., Molnar, E., Collingridge, G. L., & Bashir, Z. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1697-04.2004 · Cited by 694
Functional and Pharmacological Differences Between Recombinant N-Methyl-d-Aspartate Receptors
Vicini, S., Wang, J. F., Li, J. H., Zhu, W. J., Wang, Y. H., Luo, J. H., Wolfe, B. B., & Grayson, D. R. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.555 · Cited by 674
Regulation of NMDA receptors by tyrosine kinases and phosphatases
Wang, Y. T., & Salter, M. W. (1994) · Nature · doi:10.1038/369233a0 · Cited by 662
Graham, R. K., Deng, Y., Slow, E. J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2006.04.026 · Cited by 651
Self-citationGlutamate-induced neuron death requires mitochondrial calcium uptake
Stout, A. K., Raphael, H. M., Kanterewicz, B. I., Klann, E., & Reynolds, I. J. (1998) · Nature Neuroscience · doi:10.1038/1577 · Cited by 624
The Yin and Yang of NMDA receptor signalling
Hardingham, G. E., & Bading, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00040-1 · Cited by 620
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
Zinc potentiates agonist-lnduced currents at certain splice variants of the NMDA receptor
Hollmann, M., Boulter, J., Maron, C., Beasley, L., Sullivan, J., Pecht, G., & Heinemann, S. (1993) · Neuron · doi:10.1016/0896-6273(93)90209-a · Cited by 611
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 610
NMDA Channel Regulation by Channel-Associated Protein Tyrosine Kinase Src
Yu, X.-M., Askalan, R., Keil, G. J., & Salter, M. W. (1997) · Science · doi:10.1126/science.275.5300.674 · Cited by 608
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Self-citationWhite, R. J., & Reynolds, I. J. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-18-05688.1996 · Cited by 592
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Michaelis, E. K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00055-5 · Cited by 580
Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts
Nicholls, D. G., & Ward, M. W. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01534-9 · Cited by 563
Wellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9158 · Cited by 562
Sawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Greenamyre, J. T., Snyder, S. H., & Ross, C. A. (1999) · Nature Medicine · doi:10.1038/13518 · Cited by 552
Molecular determinants of NMDA receptor internalization
Roche, K. W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M. D., & Wenthold, R. J. (2001) · Nature Neuroscience · doi:10.1038/90498 · Cited by 550
Huntingtin–protein interactions and the pathogenesis of Huntington's disease
Li, S.-H., & Li, X.-J. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.01.008 · Cited by 548
The hunt for huntingtin function: interaction partners tell many different stories
Harjes, P., & Wanker, E. E. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00168-3 · Cited by 539
A developmental change in NMDA receptor-associated proteins at hippocampal synapses
Sans, N., Petralia, R. S., Wang, Y.-X., Blahos, J., Hell, J. W., & Wenthold, R. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01260.2000 · Cited by 537
Transcriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515
Subunit-Specific NMDA Receptor Trafficking to Synapses
Barria, A., & Malinow, R. (2002) · Neuron · doi:10.1016/s0896-6273(02)00776-6 · Cited by 515
Excitotoxicity and the NMDA receptor -- still lethal after eight years
Rothman, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93869-y · Cited by 508
Ross, C. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00872-3 · Cited by 507
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Regulation of NMDA Receptors by an Associated Phosphatase-Kinase Signaling Complex
Westphal, R. S., Tavalin, S. J., Lin, J. W., Alto, N. M., Fraser, I. D. C., Langeberg, L. K., Sheng, M., & Scott, J. D. (1999) · Science · doi:10.1126/science.285.5424.93 · Cited by 496
Tingley, W. G., Ehlers, M. D., Kameyama, K., Doherty, C., Ptak, J. B., Riley, C. T., & Huganir, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5157 · Cited by 495
Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S., & Mizuno, N. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903470112 · Cited by 486
Brouillet, E., Hantraye, P., Ferrante, R. J., Dolan, R., Leroy-Willig, A., Kowall, N. W., & Beal, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7105 · Cited by 485
Mitochondrial regulation of apoptotic cell death
Orrenius, S. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.017 · Cited by 481
Tang, T.-S., Tu, H., Chan, E. Y. W., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R., & Bezprozvanny, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00366-0 · Cited by 481
Evidence for a Tetrameric Structure of Recombinant NMDA Receptors
Laube, B., Kuhse, J., & Betz, H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02954.1998 · Cited by 480
Jenkins, B. G., Koroshetz, W. J., Beal, M. F., & Rosen, B. R. (1993) · Neurology · doi:10.1212/wnl.43.12.2689 · Cited by 478
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J.-Y., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S.-H., & Li, X.-J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 477
Excitotoxic injury of the neostriatum: a model for Huntington's disease
DiFiglia, M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90111-m · Cited by 471
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
II. Excitotoxic models for neurodegenerative disorders
Schwarcz, R., Foster, A. C., French, E. D., Whetsell, W. O., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 466
Goehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., Droege, A., Lindenberg, K. S., Knoblich, M., Haenig, C., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.016 · Cited by 453
Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E. C., & Mandel, J.-L. (1995) · Nature Genetics · doi:10.1038/ng0595-104 · Cited by 452
Erreger, K., Dravid, S. M., Banke, T. G., Wyllie, D. J. A., & Traynelis, S. F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.080028 · Cited by 427
Roles of Mitochondria in Health and Disease
Duchen, M. R. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s96 · Cited by 425
Protein kinase C modulates NMDA receptor trafficking and gating
Lan, J.-Y., Skeberdis, V. A., Jover, T., Grooms, S. Y., Lin, Y., Araneda, R. C., Zheng, X., Bennett, M. V. L., & Zukin, R. S. (2001) · Nature Neuroscience · doi:10.1038/86028 · Cited by 421
An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing
Scott, D. B., Blanpied, T. A., Swanson, G. T., Zhang, C., & Ehlers, M. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03063.2001 · Cited by 418
Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine Repeats
Sánchez, I., Xu, C.-J., Juo, P., Kakizaka, A., Blenis, J., & Yuan, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80716-3 · Cited by 412
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease
Gusella, J. F., & MacDonald, M. E. (2000) · Nature Reviews Neuroscience · doi:10.1038/35039051 · Cited by 404
Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease
Wellington, C. L., Ellerby, L. M., Gutekunst, C.-A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y.-Z., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07862.2002 · Cited by 399
Murphy, K. P. S. J., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05115.2000 · Cited by 398
NMDA Receptor Losses in Putamen from Patients with Huntington's Disease
Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I., & Penney, J. B. (1988) · Science · doi:10.1126/science.2841762 · Cited by 395
Executive and mnemonic functions in early Huntington's disease
Lawrence, A. D., Sahakian, B. J., Hodges, J. R., Rosser, A. E., Lange, K. W., & Robbins, T. W. (1996) · Brain · doi:10.1093/brain/119.5.1633 · Cited by 386
Evidence for specific cognitive deficits in preclinical Huntington's disease
Lawrence, A. (1998) · Brain · doi:10.1093/brain/121.7.1329 · Cited by 384
N-Methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease
Waxman, E. A., & Lynch, D. R. (2005) · The Neuroscientist · doi:10.1177/1073858404269012 · Cited by 372
Brinkman, R. R., Mezei, M., Theilmann, J., Almqvist, E. W., & Hayden, M. R. (1997) · Europe PMC (PubMed Central) · Cited by 368
Albin, R. L., Reiner, A., Anderson, K. D., Dure, L. S., Handelin, B., Balfour, R., Whetsell, W. O., Penney, J. B., & Young, A. B. (1992) · Annals of Neurology · doi:10.1002/ana.410310412 · Cited by 368
Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons
Stocca, G., & Vicini, S. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.013bu.x · Cited by 363
Loftis, J. M., & Janowsky, A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00302-9 · Cited by 362
Disturbed Ca2+signaling and apoptosis of medium spiny neurons in Huntington's disease
Tang, T.-S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., & Bezprozvanny, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409402102 · Cited by 360
Transgenic rat model of Huntington's disease
von Horsten, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.6.617 · Cited by 359
Li, H., Li, S.-H., Yu, Z.-X., Shelbourne, P., & Li, X.-J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08473.2001 · Cited by 359
Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001475200 · Cited by 358
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
Dragunow, M., Faull, R. L. M., Lawlor, P., Beilharz, E. J., Singleton, K., Walker, E. B., & Mee, E. (1995) · NeuroReport · doi:10.1097/00001756-199505090-00026 · Cited by 342
Cepeda, C., Hurst, R. S., Calvert, C. R., Hernández-Echeagaray, E., Nguyen, O. K., Jocoy, E., Christian, L. J., Ariano, M. A., & Levine, M. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00961.2003 · Cited by 321
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
Landwehrmeyer, G., Standaert, D., Testa, C., Penney, J., & Young, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05297.1995 · Cited by 317
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M.-F., & Levine, M. S. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.6.2667 · Cited by 314
Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
Lack of NMDA Receptor Subtype Selectivity for Hippocampal Long-Term Potentiation
Berberich, S., Punnakkal, P., Jensen, V., Pawlak, V., Seeburg, P. H., Hvalby, Ø., & Köhr, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1905-05.2005 · Cited by 302
Sun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Ferrante, R. J., Kowall, N. W., Beal, M. F., Martin, J. B., Bird, E. D., & Richardson, E. P. (1987) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198701000-00002 · Cited by 294
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., Gusella, J. F., Laramie, J. M., Myers, R. H., Lesort, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi319 · Cited by 294
Laforet, G. A., Sapp, E., Chase, K., McIntyre, C., Boyce, F. M., Campbell, M., Cadigan, B. A., Warzecki, L., Tagle, D. A., Reddy, P. H., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09112.2001 · Cited by 290
Synaptic and Extrasynaptic NMDA Receptor NR2 Subunits in Cultured Hippocampal Neurons
Thomas, C. G., Miller, A. J., & Westbrook, G. L. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00771.2005 · Cited by 285
Lessons from animal models of Huntington's disease
Rubinsztein, D. C. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02625-7 · Cited by 283
β-Adrenergic Regulation of Synaptic NMDA Receptors by cAMP-Dependent Protein Kinase
Raman, I. M., Tong, G., & Jahr, C. E. (1996) · Neuron · doi:10.1016/s0896-6273(00)80059-8 · Cited by 278
Gines, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg046 · Cited by 276
Slow, E. J., Graham, R. K., Osmand, A. P., Devon, R. S., Lu, G., Deng, Y., Pearson, J., Vaid, K., Bissada, N., Wetzel, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503634102 · Cited by 275
NMDA receptor function in mouse models of Huntington disease
Cepeda, C., Ariano, M. A., Calvert, C. R., Flores‐Hernández, J., Chandler, S. H., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1244 · Cited by 274
Sattler, R., Charlton, M. P., Hafner, M., & Tymianski, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062349.x · Cited by 273
Leonard, A. S., & Hell, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12107 · Cited by 272
Maren, S., & Baudry, M. (1995) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1995.1001 · Cited by 267
Bartlett, T. E., Bannister, N. J., Collett, V. J., Dargan, S. L., Massey, P. V., Bortolotto, Z. A., Fitzjohn, S. M., Bashir, Z. I., Collingridge, G. L., & Lodge, D. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.013 · Cited by 265
Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain
Brennan, W. A., Bird, E. D., & Aprille, J. R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07192.x · Cited by 264
Shelbourne, P. F., Killeen, N., Hevner, R. F., Johnston, H. M., Tecott, L., Lewandoski, M., Ennis, M., Ramirez, L., Li, Z., Iannicola, C., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.763 · Cited by 263
Bates, G. P., Murphy, K., Harper, P. S., & Jones, L. A. (2002) · Cited by 263
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
GUIDETTI, P., LUTHICARTER, R., AUGOOD, S., & SCHWARCZ, R. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.006 · Cited by 260
Subtype-Dependence of NMDA Receptor Channel Open Probability
Chen, N., Luo, T., & Raymond, L. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06844.1999 · Cited by 260
Self-citationA use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux
Vissel, B., Krupp, J. J., Heinemann, S. F., & Westbrook, G. L. (2001) · Nature Neuroscience · doi:10.1038/88404 · Cited by 252
Martinez-Vicente, M., Sovak, G., & Cuervo, A. M. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.005 · Cited by 245
Ferrante, R. J., Kowall, N. W., Cipolloni, P. B., Storey, E., & Beal, M. F. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1006 · Cited by 244
Albin, R. L., Young, A. B., Penney, J. B., Handelin, B., Balfour, R., Anderson, K. D., Markel, D. S., Tourtellotte, W. W., & Reiner, A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221807 · Cited by 243
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
Cha, J.-H. J., Frey, A. S., Alsdorf, S. A., Kerner, J. A., Kosinski, C. M., Mangiarini, L., Penney, J. B., Davies, S. W., Bates, G. P., & Young, A. B. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0449 · Cited by 238
Morishita, W., Lu, W., Smith, G. B., Nicoll, R. A., Bear, M. F., & Malenka, R. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.005 · Cited by 235
Preconditioning Doses of NMDA Promote Neuroprotection by Enhancing Neuronal Excitability
Soriano, F. X., Papadia, S., Hofmann, F., Hardingham, N. R., Bading, H., & Hardingham, G. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0455-06.2006 · Cited by 235
ARZBERGER, T., KRAMPFL, K., LEIMGRUBER, S., & WEINDL, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00013 · Cited by 232
Impaired Synaptic Plasticity in Mice Carrying the Huntington's Disease Mutation
Usdin, M. T., Shelbourne, P. F., Myers, R. M., & Madison, D. V. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.839 · Cited by 230
Huntington's disease: the challenge for cell biologists
Tobin, A. J., & Signer, E. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01853-5 · Cited by 229
Laurie, D. J., Bartke, I., Schoepfer, R., Naujoks, K., & Seeburg, P. H. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00206-4 · Cited by 224
Greene, J. G., Porter, R. H. P., Eller, R. V., & Greenamyre, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03634.x · Cited by 208
Clinical markers of early disease in persons near onset of Huntington’s disease
Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., Como, P., Manning, C., Hayden, M. R., Shoulson, I., et al. (2001) · Neurology · doi:10.1212/wnl.57.4.658 · Cited by 204
Mutant Huntingtin Enhances Excitotoxic Cell Death
Zeron, M. M., Chen, N., Moshaver, A., Ting-Chun Lee, A., Wellington, C. L., Hayden, M. R., & Raymond, L. A. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0909 · Cited by 197
Self-citationCAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain
Aronin, N., Chase, K., Young, C., Sapp, E., Schwarz, C., Matta, N., Kornreich, R., Lanwehrmeyer, B., Bird, E., Beal, M. F., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90106-x · Cited by 187
Scott, D. B., Blanpied, T. A., & Ehlers, M. D. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00250-8 · Cited by 186
Li, J. H., Wang, Y. H., Wolfe, B. B., Krueger, K. E., Corsi, L., Stocca, G., & Vicini, S. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00169.x · Cited by 186
Biochemical abnormalities in Huntington's chorea brains
STAHL, W. L., & SWANSON, P. D. (1974) · Neurology · doi:10.1212/wnl.24.9.813 · Cited by 185
Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
Saft, C., Zange, J., Andrich, J., Müller, K., Lindenberg, K., Landwehrmeyer, B., Vorgerd, M., Kraus, P. H., Przuntek, H., & Schöls, L. (2005) · Movement Disorders · doi:10.1002/mds.20373 · Cited by 183
Privileged Access to Mitochondria of Calcium Influx throughN-Methyl-d-Aspartate Receptors
Peng, T.-I., & Greenamyre, J. T. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13266-x · Cited by 182
Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., & Raymond, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721890.x · Cited by 180
Self-citationGutekunst, C.-A., Li, S.-H., Yi, H., Ferrante, R. J., Li, X.-J., & Hersch, S. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07674.1998 · Cited by 179
Increased Susceptibility of Striatal Mitochondria to Calcium-Induced Permeability Transition
Brustovetsky, N., Brustovetsky, T., Purl, K. J., Capano, M., Crompton, M., & Dubinsky, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04858.2003 · Cited by 177
Hantraye, P., Riche, D., Maziere, M., & Isacson, O. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90014-j · Cited by 175
Ca 2+ signals and death programmes in neurons
Berliocchi, L., Bano, D., & Nicotera, P. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1765 · Cited by 174
Van Raamsdonk, J. M., Pearson, J., Rogers, D. A., Bissada, N., Vogl, A. W., Hayden, M. R., & Leavitt, B. R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi147 · Cited by 173
Complex I Defect in muscle from patients with Huntington's disease
Arenas, J., Campos, Y., Ribacoba, R., Martín, M. A., Rubio, J. C., Ablanedo, P., & Cabello, A. (1998) · Annals of Neurology · doi:10.1002/ana.410430321 · Cited by 173
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease
Milnerwood, A. J., Cummings, D. M., Dallérac, G. M., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., Rezaie, P., & Murphy, K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl092 · Cited by 171
Zeron, M. M., Fernandes, H. B., Krebs, C., Shehadeh, J., Wellington, C. L., Leavitt, B. R., Baimbridge, K. G., Hayden, M. R., & Raymond, L. A. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.11.014 · Cited by 170
Self-citationElevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E. J., Wheeler, V. C., Woodman, B., & Schwarcz, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 165
Huntington’s disease: A randomized, controlled trial using the NMDA-antagonist amantadine
Verhagen Metman, L., Morris, M. J., Farmer, C., Gillespie, M., Mosby, K., Wuu, J., & Chase, T. N. (2002) · Neurology · doi:10.1212/wnl.59.5.694 · Cited by 162
Differential regulation of synaptic and extra-synaptic NMDA receptors
Li, B., Chen, N., Luo, T., Otsu, Y., Murphy, T. H., & Raymond, L. A. (2002) · Nature Neuroscience · doi:10.1038/nn912 · Cited by 160
Self-citationInfluence of lamotrigine on progression of early Huntington disease: A randomized clinical trial
Kremer, B. P. H., Clark, C. M., Almqvist, E. W., Raymond, L. A., Graf, P., Jacova, C., Mezei, M., Hardy, M., Snow, B. J., Martin, W. R. W., et al. (1999) · Neurology · doi:10.1212/wnl.53.5.1000 · Cited by 160
Self-citationMcIlhinney, R. A. J., Bourdellès, B. L., Molnár, E., Tricaud, N., Streit, P., & Whiting, P. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00121-x · Cited by 160
The quinolinic acid model of Huntington's disease: Locomotor abnormalities
Sanberg, P. R., Calderon, S. F., Giordano, M., Tew, J. M., & Norman, A. B. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90170-2 · Cited by 159
Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Bonelli, R. M., & Wenning, G. K. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698693 · Cited by 157
Multiple effects of phorbol esters in the rat spinal dorsal horn
Gerber, G., Kangrga, I. M., Pd, R., Larew, J., & Randić, M. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-10-03606.1989 · Cited by 156
Gingrich, J. R., Pelkey, K. A., Fam, S. R., Huang, Y., Petralia, R. S., Wenthold, R. J., & Salter, M. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401413101 · Cited by 147
Leenders, K. L., Frackowiak, R. S. J., Quinn, N. P., & MARSDEN, C. D. (1986) · Movement Disorders · doi:10.1002/mds.870010110 · Cited by 144
Standaert, D. G., Friberg, I. K., Landwehrmeyer, G. B., Young, A. B., & Penney, J. B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00293-9 · Cited by 143
Ethyl-EPA in Huntington disease
Puri, B. K., Leavitt, B. R., Hayden, M. R., Ross, C. A., Rosenblatt, A., Greenamyre, J. T., Hersch, S. M., Vaddadi, K. S., Sword, A., Horrobin, D. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000169025.09670.6d · Cited by 141
N-Methyl-D-aspartate Receptors: Subunit Assembly and Trafficking to the Synapse
Prybylowski, K., & Wenthold, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300029200 · Cited by 137
Wang, Y. T., Yu, X. M., & Salter, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1721 · Cited by 137
3‐Nitropropionic Acid Toxicity in the Striatum
Wüllner, U., Young, A. B., Penney, J. B., et al. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051772.x · Cited by 137
Shehadeh, J., Fernandes, H. B., Mullins, M. Z., Graham, R. K., Leavitt, B. R., Hayden, M. R., & Raymond, L. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.001 · Cited by 136
Self-citationKehoe, P. G., Krawczak, M., Harper, P. S., Owen, M. J., & Jones, A. L. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.2.108 · Cited by 134
Zheng, X., Zhang, L., Wang, A. P., Bennett, M. V. L., & Zukin, R. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15262 · Cited by 130
Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease
Li, L., Fan, M., Icton, C. D., Chen, N., Leavitt, B. R., Hayden, M. R., Murphy, T. H., & Raymond, L. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.003 · Cited by 128
Self-citationGreene, J. G., & Greenamyre, J. T. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010430.x · Cited by 120
Regulation of N-Methyl-d-Aspartate Receptor Function by Constitutively Active Protein Kinase C
Xiong, Z., Raouf, R., Lu, W.-Y., Wang, L., Orser, B. A., Dudek, E. M., Browning, M. D., & MacDonald, J. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1055 · Cited by 118
The role of NMDAR subtypes and charge transfer during hippocampal LTP induction
Berberich, S., Jensen, V., Hvalby, Ø., Seeburg, P. H., & Köhr, G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.016 · Cited by 117
Mazarakis, N. K., Cybulska-Klosowicz, A., Grote, H., Pang, T., Van Dellen, A., Kossut, M., Blakemore, C., & Hannan, A. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4320-04.2005 · Cited by 115
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.11.002 · Cited by 114
Neurotransmitter glutamate: its clinical importance
Engelsen, B. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb03524.x · Cited by 114
K�ppenbender, K. D., Standaert, D. G., Feuerstein, T. J., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000417)419:4<407::aid-cne1>3.0.co;2-i · Cited by 113
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease
Arning, L., Kraus, P. H., Valentin, S., Carsten Saft, C., Andrich, J., & Epplen, J. T. (2004) · Neurogenetics · doi:10.1007/s10048-004-0198-8 · Cited by 113
A controlled trial of remacemide hydrochloride in Huntington's disease
Kieburtz, K. D., Feigin, A., McDermott, M., Como, P. G., Abwender, D. A., Zimmerman, C. F., Hickey, C., Orme, C., Claude, K., Sotack, J., et al. (1996) · Movement Disorders · doi:10.1002/mds.870110310 · Cited by 113
Neuroprotection in Huntington??s disease: a 2-year study on minocycline
Bonelli, R. M., dl, A. K. H., Hofmann, P., & Kapfhammer, H. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200411000-00004 · Cited by 111
Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum
Bizière, K., & Coyle, J. T. (1979) · Journal of Neuroscience Research · doi:10.1002/jnr.490040507 · Cited by 111
Minocycline in Huntington's disease: A pilot study
Thomas, M., Ashizawa, T., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.20018 · Cited by 111
Li, L., Murphy, T. H., Hayden, M. R., & Raymond, L. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00308.2004 · Cited by 106
Self-citationLuthi-Carter, R., Apostol, B. L., Dunah, A. W., DeJohn, M. M., Farrell, L. A., Bates, G. P., Young, A. B., Standaert, D. G., Thompson, L. M., & Cha, J.-H. J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.024 · Cited by 104
Rigby, M., Bourdellès, B. L., HEAVENS, R. P., Kelly, S., Smith, D. W., Butler, A., Hammans, R., Hills, R., Xuereb, J. H., Hill, R. G., et al. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00089-9 · Cited by 103
Brustovetsky, N., LaFrance, R., Purl, K. J., Brustovetsky, T., Keene, C. D., Low, W. C., & Dubinsky, J. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03036.x · Cited by 102
High-dose creatine therapy for Huntington disease: A 2-year clinical and MRS study
Tabrizi, S. J., Blamire, A. M., Manners, D. N., Rajagopalan, B., Styles, P., Schapira, A. H. V., & Warner, T. T. (2005) · Neurology · doi:10.1212/01.wnl.0000160388.96242.77 · Cited by 100
Song, C., Zhang, Y.-T., Parsons, C., & Liu, Y.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304240200 · Cited by 100
Starling, A. J., André, V. M., Cepeda, C., de Lima, M., Chandler, S. H., & Levine, M. S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20651 · Cited by 99
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease
Beister, A., Kraus, P., Kuhn, W., Dose, M., Weindl, A., & Gerlach, M. (2004) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0579-5_14 · Cited by 98
Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model
Jarabek, B. R., Yasuda, R. P., & Wolfe, B. B. (2003) · Brain · doi:10.1093/brain/awh058 · Cited by 96
Cited by
Synaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Striatal Plasticity and Basal Ganglia Circuit Function
Kreitzer, A. C., & Malenka, R. C. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.005 · Cited by 1,017
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Metadata
- Authors
- FAN, M., & RAYMOND, L.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 81
- Issue
- 5-6
- Pages
- 272-293
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1998237974
- Cited by
- 413
- References
- 229
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.